Kmpharmaceutical Co (XKRX:225430) E10: ₩-604.50 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKRX:225430 Kmpharmaceutical Co Ltd XKRX:225430
60 GF Score
Price ₩1,787.00
GF Value ₩3,768.47
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Kmpharmaceutical Co E10?

Kmpharmaceutical Co XKRX:225430 -5.55% 60 E10 is ₩-604.50 as of Mar. 2026. GuruFocus rates XKRX:225430 with a GF Score™ of 60/100 and a GF Value™ of ₩3,768.47 (Possible Value Trap). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Kmpharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was ₩-150.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₩-604.50 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-08-10), Kmpharmaceutical Co's current stock price is ₩1787.00. Kmpharmaceutical Co's E10 for the quarter that ended in Mar. 2026 was ₩-604.50. Kmpharmaceutical Co's Shiller PE Ratio of today is .


Kmpharmaceutical Co  (XKRX:225430) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Kmpharmaceutical Co E10 Related Terms


Kmpharmaceutical Co E10 Historical Data

* Premium members only.

The historical data trend for Kmpharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kmpharmaceutical Co E10 Chart

Kmpharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -582.05

Kmpharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -573.45 -582.05 -604.50

XKRX:225430 vs BLK, BX, KKR: E10 Comparison

For the Asset Management subindustry, Kmpharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kmpharmaceutical Co Shiller PE Ratio vs Asset Management Industry

For the Asset Management industry and Financial Services sector, Kmpharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Kmpharmaceutical Co's Shiller PE Ratio falls into.


XKRX:225430
60GF Score
Kmpharmaceutical Co Ltd XKRX:225430
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kmpharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Kmpharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-150/125.2360*125.2360
=-150.000

Current CPI (Mar. 2026) = 125.2360.

Kmpharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201606 10.940 100.791 13.593
201609 -0.476 101.461 -0.588
201612 1.427 101.561 1.760
201703 8.086 102.851 9.846
201706 -23.307 102.611 -28.446
201709 95.131 103.491 115.120
201712 546.057 102.991 664.001
201803 114.157 104.101 137.334
201806 52.322 104.130 62.927
201809 -3,714.852 105.651 -4,403.512
201812 294.905 104.351 353.929
201903 28.539 104.491 34.205
201906 33.296 104.881 39.758
201909 -52.322 105.200 -62.287
201912 -214.044 105.121 -255.001
202003 90.374 105.354 107.429
202006 47.565 105.112 56.672
202009 -42.809 106.198 -50.484
202012 14.869 105.765 17.606
202103 5.000 107.357 5.833
202106 20.000 107.579 23.283
202109 -75.000 108.759 -86.362
202112 -60.000 109.676 -68.512
202203 -5.000 111.848 -5.598
202206 -85.000 114.072 -93.319
202209 -180.000 114.715 -196.508
202212 -430.000 115.179 -467.545
202303 -5.000 116.507 -5.375
202306 30.000 117.182 32.062
202309 -90.000 118.964 -94.745
202312 -170.000 118.837 -179.154
202403 -95.000 120.123 -99.043
202406 -220.000 120.007 -229.585
202409 -170.000 120.861 -176.153
202412 -335.000 121.135 -346.341
202503 -150.000 122.590 -153.238
202506 -170.000 122.611 -173.639
202509 -185.000 123.402 -187.750
202512 -205.000 123.939 -207.145
202603 -150.000 125.236 -150.000

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₩-604.50 mean?
Kmpharmaceutical Co (XKRX:225430) has a E10 of ₩-604.50 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Kmpharmaceutical Co and its competitors.
Is Kmpharmaceutical Co's E10 too high?
Kmpharmaceutical Co's current E10 is ₩-604.50. Overall, Kmpharmaceutical Co has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Kmpharmaceutical Co's E10 compare to BLK and BX?
Kmpharmaceutical Co's E10 of ₩-604.50 can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for an Asset Management company?
A good E10 depends on the Asset Management industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Kmpharmaceutical Co and its competitors. Kmpharmaceutical Co's current E10 is ₩-604.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kmpharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Kmpharmaceutical Co (XKRX:225430) is currently considered Possible Value Trap. The stock's GF Value™ is ₩3,768.47, compared to a current price of ₩1,787.00 — trading 52.6% below its estimated fair value. The current E10 is ₩-604.50. Kmpharmaceutical Co's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Kmpharmaceutical Co (XKRX:225430), the current E10 is ₩-604.50 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kmpharmaceutical Co (XKRX:225430) Overvalued in 2026?

Based on GuruFocus' analysis, Kmpharmaceutical Co stock appears to be undervalued. The current stock price of ₩1,787.00 is trading 52.6% below its estimated GF Value™ of ₩3,768.47. GuruFocus considers Kmpharmaceutical Co to be Possible Value Trap.

Key valuation signals for XKRX:225430:

  • E10: ₩-604.50
  • GF Value™: ₩3,768.47 vs. price of ₩1,787.00 (52.6% below fair value)
  • GF Score™: 60/100 with 5 warning signs

No single metric tells the full story. See the XKRX:225430 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kmpharmaceutical Co Business Description

Address Six road-dong, Yeongdeungpo-gu, Triple-floor building 6, Seoul International Finance 11 (dong), Seoul, KOR, 07330
Kmpharmaceutical Co Ltd, formerly IBKS No.3 Special Purpose Acquisition Co is engaged in auxiliary to financial service activities.
60GF Score

Get the complete analysis for XKRX:225430

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩1,787.00
Price
₩3,768.47
GF Value